In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pharmacotherapy in Older People

Training course of the ESC Working Group on Cardiovascular Pharmacotherapy

16/05/2019 00:00 16/05/2019 00:00 Europe/Paris Pharmacotherapy in Older People ESC Working Group on Cardiovascular Pharmacotherapy contact@escardio.org true DD/MM/YYYY
Cardiovascular Pharmacotherapy
Cardiovascular Disease in the Elderly
In-person
event

Summary

The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to present an engaging and interactive course to improve the professional knowledge and skills for cardiovascular pharmacotherapy in older patients.

The course will be held on 16 May in Vienna, one day prior to EuroCVP 2019, the annual meeting of the Working Group.



Introduction

In Europe and the Western World in particular, the proportion of older persons is dramatically increasing, which is predicted to add tremendous extra pressure to the strained health care systems.

Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid lowering drugs and glucose lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.

Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on services and patient outcomes. 

Scientific Programme

The programme with faculty will be available soon.

Time

Title

08:30 REGISTRATION

09:00

Welcome, introduction and course objectives

Thomas A Schmidt, Keld Kjeldsen, Heinz Drexel

SESSION 1. GENERAL ASPECTS

09:10

Demographical developments, and feasibility of treating older patients in a short stay unit, the “Elder” trial.

 

09:30

Drug metabolism in older people

 

SESSION 2. DIURETICS

10:00

Hypo- and hyperkalemia

 

10:30

Refreshments and networking

SESSION 3. ANTIHYPERTENSIVES

10:45

Benefit versus drawback of blood pressure treatment in older patients

 

SESSION 4. NOACs

11:15

Benefit versus drawback of NOAC treatment in older patients

 

11:30

WORKSHOP INCLUDING CASE STORIES

 

12:00

Lunch and networking

SESSION 5. ANTIARRHYTHMICS

13:00

Atrial fibrillation + case story

 

SESSION 6. LIPID LOWERING DRUGS

13:30

Lipidology + case story

 

14:00

Refreshments and networking

SESSION 7. GLUCOSE LOWERING DRUGS

14:30

Tight glycemic control, pros and cons

 

SESSION 8. POLYPHARMACY

15:00

Polypharmacy in older people

15:20

WORKSHOP INCLUDING CASE STORIES

Plenary

16:00 – 16:30

Refreshments and networking

 

Registration

Registration is open: please visit the website here.

Course directors

Thomas A Schmidt, MD, DSc, FESC

Keld Kjeldsen, MD, DSc

Heinz Drexel, MD, DSc, FESC